<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27573827</article-id>
<article-id pub-id-type="pmc">5027464</article-id>
<article-id pub-id-type="publisher-id">201607571</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1607571113</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Medical Sciences</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Metabolic features of chronic fatigue syndrome</article-title>
<alt-title alt-title-type="short">Metabolic features of chronic fatigue syndrome</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Naviaux</surname>
<given-names>Robert K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Naviaux</surname>
<given-names>Jane C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Kefeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bright</surname>
<given-names>A. Taylor</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alaynick</surname>
<given-names>William A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Lin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baxter</surname>
<given-names>Asha</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nathan</surname>
<given-names>Neil</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anderson</surname>
<given-names>Wayne</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gordon</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>The Mitochondrial and Metabolic Disease Center, <institution>University of California, San Diego School of Medicine</institution>, San Diego, <addr-line>CA</addr-line> 92103-8467;</aff>
<aff id="aff2"><sup>b</sup>Department of Medicine, <institution>University of California, San Diego School of Medicine</institution>, San Diego, <addr-line>CA</addr-line> 92103-8467;</aff>
<aff id="aff3"><sup>c</sup>Department of Pediatrics, <institution>University of California, San Diego School of Medicine</institution>, San Diego, <addr-line>CA</addr-line> 92103-8467;</aff>
<aff id="aff4"><sup>d</sup>Department of Pathology, <institution>University of California, San Diego School of Medicine</institution>, San Diego, <addr-line>CA</addr-line> 92103-8467;</aff>
<aff id="aff5"><sup>e</sup>Department of Neurosciences, <institution>University of California, San Diego School of Medicine</institution>, San Diego, <addr-line>CA</addr-line> 92103-8467;</aff>
<aff id="aff6"><sup>f</sup><institution>Gordon Medical Associates</institution>, Santa Rosa, <addr-line>CA</addr-line> 95403</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence should be addressed. Email: <email>rnaviaux@ucsd.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Ronald W. Davis, Stanford University School of Medicine, Stanford, CA, and approved July 13, 2016 (received for review May 11, 2016)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: R.K.N., N.N., W.A., and E.G. designed research; R.K.N., J.C.N., K.L., A.T.B., L.W., A.B., N.N., W.A., and E.G. performed research; R.K.N., J.C.N., K.L., A.T.B., W.A.A., and L.W. contributed new reagents/analytic tools; R.K.N. wrote and managed the human subjects protocol; J.C.N. recruited subjects and developed methods; K.L. developed methods; A.T.B. created the pathway database and developed new bioinformatic methods; W.A.A. prepared the Cytoscape pathway visualizations; A.B. coordinated patient recruitment, medical histories, and clinical data; N.N., W.A., and E.G. identified and recruited patients; R.K.N., J.C.N., K.L., A.T.B., N.N., and E.G. analyzed data; and R.K.N., J.C.N., K.L., A.T.B., and W.A.A. wrote the paper.</p>
</fn>
<fn fn-type="present-address" id="fn1">
<p><sup>2</sup>Present address: Redwood Valley Clinic, 8501 West Road, Redwood Valley, CA, 95470.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>13</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>29</day>
<month>8</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>113</volume>
<issue>37</issue>
<fpage>E5472</fpage>
<lpage>E5480</lpage>
<permissions>
<license license-type="open-access">
<license-p>Freely available online through the PNAS open access option.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201607571.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Chronic fatigue syndrome is a multisystem disease that causes long-term pain and disability. It is difficult to diagnose because of its protean symptoms and the lack of a diagnostic laboratory test. We report that targeted, broad-spectrum metabolomics of plasma not only revealed a characteristic chemical signature but also revealed an unexpected underlying biology. Metabolomics showed that chronic fatigue syndrome is a highly concerted hypometabolic response to environmental stress that traces to mitochondria and was similar to the classically studied developmental state of dauer. This discovery opens a fresh path for the rational development of new therapeutics and identifies metabolomics as a powerful tool to identify the chemical differences that contribute to health and disease.</p>
</abstract>
<abstract>
<p>More than 2 million people in the United States have myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). We performed targeted, broad-spectrum metabolomics to gain insights into the biology of CFS. We studied a total of 84 subjects using these methods. Forty-five subjects (<italic>n</italic> = 22 men and 23 women) met diagnostic criteria for ME/CFS by Institute of Medicine, Canadian, and Fukuda criteria. Thirty-nine subjects (<italic>n</italic> = 18 men and 21 women) were age- and sex-matched normal controls. Males with CFS were 53 (±2.8) y old (mean ± SEM; range, 21–67 y). Females were 52 (±2.5) y old (range, 20–67 y). The Karnofsky performance scores were 62 (±3.2) for males and 54 (±3.3) for females. We targeted 612 metabolites in plasma from 63 biochemical pathways by hydrophilic interaction liquid chromatography, electrospray ionization, and tandem mass spectrometry in a single-injection method. Patients with CFS showed abnormalities in 20 metabolic pathways. Eighty percent of the diagnostic metabolites were decreased, consistent with a hypometabolic syndrome. Pathway abnormalities included sphingolipid, phospholipid, purine, cholesterol, microbiome, pyrroline-5-carboxylate, riboflavin, branch chain amino acid, peroxisomal, and mitochondrial metabolism. Area under the receiver operator characteristic curve analysis showed diagnostic accuracies of 94% [95% confidence interval (CI), 84–100%] in males using eight metabolites and 96% (95% CI, 86–100%) in females using 13 metabolites. Our data show that despite the heterogeneity of factors leading to CFS, the cellular metabolic response in patients was homogeneous, statistically robust, and chemically similar to the evolutionarily conserved persistence response to environmental stress known as dauer.</p>
</abstract>
<kwd-group>
<kwd>chronic fatigue syndrome</kwd>
<kwd>metabolomics</kwd>
<kwd>mitochondria</kwd>
<kwd>dauer</kwd>
<kwd>cell danger response</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">The UCSD Christini Fund</funding-source>
<award-id rid="sp1">1999-Present</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">The Wright Family Foundation</funding-source>
<award-id rid="sp2">2012-Present</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">The Lennox Foundation</funding-source>
<award-id rid="sp3">2012-Present</award-id>
</award-group>
<award-group id="gs4">
<funding-source id="sp4">The Jane Botsford Johnson Foundation</funding-source>
<award-id rid="sp4">2011-2014</award-id>
</award-group>
<award-group id="gs5">
<funding-source id="sp5">Tonye Marie Castenada</funding-source>
<award-id rid="sp5">2014-2016</award-id>
</award-group>
<award-group id="gs6">
<funding-source id="sp6">Tom Eames</funding-source>
<award-id rid="sp6">2014-2015</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>